While genetic factors are known to play a significant role in their development, specifically mutations in the breast cancer 1 (BRCA1) and breast cancer 2 (BRCA2) genes, it is important to note that not all breast and ovarian cancer patients carry these specific mutations. This evidence concerns the gene BRCA2 and ovarian carcinoma.